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Abstract  
Background: Epidemiological evidence from developed countries indicates that Helicobacter 
pylori infection correlates with a reduced risk of atopy and allergic disorders, however limited 
data are available from low-income countries. 
Objective: We examined associations between H. pylori infection in early childhood and atopy 
and reported allergic disorders at the age of 6.5 years in an Ethiopian birth cohort. 
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Methods: A total of 856 children (85.1% of the 1006 original singletons in a population-based 
birth cohort) were followed up at age six and half years. An interviewer-led questionnaire 
administered to mothers provided information on demographic and lifestyle variables. 
Questions on allergic disease symptoms were based on the International Study of Asthma and 
Allergies in Children (ISAAC) core allergy and environmental questionnaire. Serum samples 
were analysed for total IgE levels and anti-H. pylori cytotoxin associated gene A (CagA) IgG 
antibody using commercially available ELISA kits. Stool samples were analysed for H. pylori 
antigen using a rapid immunochromatographic test. The independent effects of H. pylori 
infection (measured at age 3, 5 and 6.5 years) on prevalence and incidence of atopy and 
reported allergic disorders (measured at age 6.5 years) were determined using multiple logistic 
regression. 
Results: In cross-sectional analysis, current H. pylori infection at age 6.5 years was 
inversely, though not significantly, related to prevalence of atopy 
and 'any allergic condition' at age 6.5 years. However detection of 
H. pylori infection at any point up to age 6.5 years was associated 
with a significantly reduced odds of both atopy and 'any allergic 
condition’ (adjusted OR AOR, 95% CI, 0.54; 0.32 to 0.92, p=0.02, and 0.31; 0.10 to 
0.94, p=0.04, respectively). In longitudinal analyses, H. pylori infection at age 3 was inversely 
associated with incidence of atopy (AOR, 95% CI, 0.49; 0.27 to 0.89, p=0.02).  Furthermore, 
among H. pylori infected children, those with a CagA+ strain had a more pronounced reduction 
in odds of atopy (AOR=0.35 vs. 0.63 for CagA+ vs. CagA-) and this reduction reached borderline 
significance. 
Conclusion: These data are consistent with the hypothesis that early exposure to H. pylori is 
inversely associated with atopy and allergic conditions. A possible modest protective 
association against atopy was observed in those infected with a more virulent CagA+ strain of H. 
pylori. 
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Introduction  
The prevalence of IgE-mediated atopy and allergic diseases has been increasing considerably 
over the past 30 years, and this is particularly apparent in developed countries(1, 2). In 
conjunction with evidence from other developing and transitional societies (3, 4), this indicates 
that factors associated with urbanization and/or relative affluence are likely to be responsible 
for these emerging allergic disorders. A potential explanation for this was given by Strachan, 
who first proposed the hygiene hypothesis (5). The ‘hygiene hypothesis’ (now revised as the 
‘old friends hypothesis’) (6) postulates that the rise of allergic disease in recent decades is 
attributable to a decrease in exposure to certain microbes and infections during childhood, and 
has gained wide acceptance (7).  Microbial infections, which are less prevalent in populations 
with improved lifestyles and better hygiene, may play a protective role in the aetiology of 
asthma and allergy (8, 9). Several viral and parasitic pathogens, including influenza viruses and 
helminths have been reported to play a role in protection against asthma and allergy (10, 11). 
Helicobacter pylori is a common bacterium, which is estimated to be present in the stomach of 
around half the world’s population. It usually colonises the gastric mucosa from early childhood, 
where it persists lifelong unless treated with antibiotics. It is the major cause of peptic 
ulceration and gastric cancer, however disease occurs in only 10-15% of cases and the infection 
usually remains asymptomatic. H. pylori has co-evolved with humans over thousands of years, 
however the prevalence of the infection (particularly amongst children in developed countries) 
has been declining rapidly over the last two decades (12-14).  Important epidemiologic 
evidence for the role of H. pylori in the hygiene hypothesis has recently emerged, and the 
infection has been associated with a reduced risk of allergic disorders including asthma (15), 
wheeze (16), eczema (17-19) , and atopy (20-22). This association has also been reported to be 
stronger with more pathogenic strains of H. pylori which express the virulence factor cytotoxin 
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associated gene A (CagA) (23, 24).  Infection with these strains reportedly induces a higher-level 
T-helper 1 (Th1) cellular immune response (24, 25), which may counterbalance the pro-allergic 
Th2 response. CagA+ strains usually also co-express the most active form of the vacuolating 
cytotoxin A (VacA), and this is important in the induction of immunosuppressive regulatory T 
cell (Treg) responses (26). Higher frequencies of IL-10-secreting Tregs were shown to be 
present in the peripheral blood of H. pylori-infected patients in the UK, and serum IgE 
concentrations were lowest when there was a strong Treg response. Mechanistic in vitro 
experiments showed that the systemic IL-10+ Treg response is likely to play an important role 
in H. pylori-mediated protection against allergy in humans (26).  A number of studies with 
mouse models of allergy and asthma have very convincingly demonstrated that H. pylori 
infection is protective and that VacA-induced Tregs play a major role (27-29). Despite this 
convincing evidence, however, others have reported no epidemiological association between 
the infection and asthma (30, 31) or atopy  (31, 32).  This inconsistency may be attributed to the 
way in which allergic disease is defined or the heterogeneity of the study designs and study 
populations.  
 
Our recent meta-analysis, using 16 observational studies showed a significant protective effect 
of H. pylori infection against objectively measured atopy (33).  However, most studies included 
in this analysis were cross-sectional, with only two prospective studies (34, 35), based in adult 
high-income country populations, and lacked data on children from low-income countries. This 
is important as infection with H. pylori is usually acquired very early in childhood (36), when 
the immune system is developing. It is possible that timing of exposure to H. pylori infection 
may be important in modulating its effects, and any long-term protection that arises from 
effects occurs during the crucial early period of immune development.  
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Our previous work on the Butajira Birth Cohort in rural Ethiopia demonstrated an inverse 
association of H. pylori infection with skin sensitization to either D. pteronyssinus or cockroach 
allergen (37) measured by skin prick test at age 5. Although this method provides a convenient 
test for atopy in epidemiological studies (38), and the allergens used are believed to be 
predominant in Ethiopian populations(8), this approach will not necessarily identify all cases of 
atopy. It is therefore important to consider atopy as defined in terms of total serum IgE, since it 
has been suggested that this provides an overall estimate of allergic disorders (39, 40). We 
therefore expanded our previous observations by collecting additional data on total serum IgE 
levels when the child reached 6.5 years, in order to investigate a possible association between 
atopy (defined by a raised total serum IgE level) and H. pylori infection. Additionally, and for the 
first time in this cohort, we also tested whether the presence of a CagA+ H. pylori strain was 
associated with atopy and allergic conditions. 
   
METHODS 
Study Setting and Design 
A detailed description of the original Butajira birth cohort study has been published previously 
(17, 41). Briefly, the birth cohort is nested in the Butajira Demographic Surveillance Site (42) 
which covers a sample of nine rural and one urban administrative units in and around the town 
of Butajira in Southern Ethiopia (43). Between July 2005 and February 2006, all women in the 
DSS aged 15–49 and in their third trimester of pregnancy were identified by the DSS 
fieldworkers and invited to participate in the study. Of the 1,234 eligible women, 1,065 were 
recruited (86% of those eligible) and all live singleton babies born to these women (n = 1006) 
were followed-up as a birth cohort (figure 1).   
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Measurement and Data collection  
At age 6.5 follow-ups visits took place, where the same project data collectors visited the child at 
home and collected information related to allergic outcomes. Questions on allergic disease 
symptoms were based on the International Study of Asthma and Allergies in Children (ISAAC) 
core allergy and environmental questionnaire (44), and included wheeze ('In the last 12 months 
has your child had wheezing or whistling in their chest?'), asthma ('In the last 12 months has your 
child had asthma?'), hay fever (‘In the last 12 months has your child had problems with sneezing 
or running nose (when not affected by cold or flu), or problems with itchy watery eyes?’) and 
eczema ('In the last 12 months has your child ever had an itchy skin rash which has affected the 
skin creases, eg, front of the elbow, behind the knees, the front of the ankles, around the neck, or 
around the eyes?’). The questionnaire also asked about various potential confounders including 
environmental factors (sanitation and water supply, household roof/wall/floor type, indoor 
smoking, presence of animals, insecticide use, cooking facilities), asthma and allergy in the 
family, household size, child’s sleeping place, siblings, birth order, and child’s use of medication 
(use of paracetamol and antibiotics).  
 
In addition to the questionnaire data, at the age 3, 5 and 6.5 year visits, mothers were also asked 
to collect a faecal sample from their child using a leak-proof plastic container.  The samples 
were then transported for analysis in the Butajira Health Center laboratory to ascertain the 
child's H. pylori and intestinal parasite infection status. Furthermore, at the 6.5 year visit, a 5 ml 
blood sample was collected from each child using a vacutainer tube. Serum samples were 
separated within 2 hrs. of collection at Butajira hospital and then transported to the Ethiopian 
Public Health Institute (EPHI) Research Laboratory, Addis Ababa for serum CagA and IgE ELISA 
analyses.  
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Laboratory analyses  
H. pylori status  
H. pylori status was evaluated using the commercially available SD Bioline H. pylori stool antigen 
test (Standard Diagnostics, Inc) according to the manufacturer's instructions. A portion of faeces 
(approximately 50mg) from each stool sample was mixed with assay diluent solution, until the 
sample had been dissolved, before allowing the suspension to settle for 5 minutes at room 
temperature. 100 µL of the liquid phase of the sample was placed on the H. pylori Ag test strip. 
The test results were checked after 15 minutes, where one red line indicated a negative result 
and a double red line indicated a H. pylori positive result. 
 
Additionally, all faecal samples were examined qualitatively using the modified formol-ether 
concentration method to ascertain the child's intestinal parasites infection status.  
 
H. pylori CagA status 
Serum anti-CagA IgG antibody status was assessed using a commercial enzyme-linked 
immunosorbent assay (ELISA) kit (Genesis Diagnostics Ltd, UK), as per the manufacturer’s 
instructions. The optical densities of the wells were measured using a microplate reader at 
450nm.  Values above the 6.25 U/ml standard were defined as positive. According to the 
manufacturer, the sensitivity and specificity of this kit are 96.3 % and 96.7 %, respectively.  
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Total IgE analysis 
Total IgE levels were measured using a commercially available ELISA kit (Omega diagnostic, 
UK), according to the manufacturer’s instructions.  The optical densities (ODs) of the standards, 
positive control and samples were measured using a microplate reader at 450nm.  Elevated IgE 
levels were determined based on the manufacturer’s recommended threshold by age range. For 
this study total IgE levels greater than 144 IU/ml for age 5-10 were considered as the cut-off 
value to define atopy.  
 
Outcome definition 
Atopy was defined in this study as an elevated total serum IgE. A total serum IgE concentration 
of ≤ 144 IU/ml for children aged 5-10 years was considered to be normal based on reference 
ranges provided by the manufacturer’s recommended threshold by age range.  
'Any allergic condition' was defined as a positive response to one or more of the questions on 
asthma, hay fever and eczema in the past 12 months, at years 6.5 follow-up.  
 
Statistical analysis  
Data were double entered into EpiData 3.1 (EpiData, Denmark). The datasets were cleaned, 
coded and merged ready for analysis using Stata 12 (Statacorp, College Station, Texas, USA). 
Prior to investigating the association between H. pylori infection and atopy, univariate analyses 
were used to identify the possible confounders. Variables that were associated with both 
exposure and outcome variables in the crude analysis using statistical significance at p value 
<0.2 were considered to be possible confounders. Additionally, we included variables 
previously shown to be associated with atopy and /or elevated total IgE in the literature; child’s 
sex (45), smoking (46), antibiotic use (47) and intestinal parasite status (48)  
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We estimated odds ratios (ORs) associated with H. pylori positivity for atopy and 'any allergic 
condition' using multivariate logistic regression. The ORs were adjusted for a priori and 
potential confounders listed in Table S1. The same approach was used in a separate set of 
analyses to assess the effect of CagA H. pylori strain infection on atopy and self-reported allergic 
symptoms for all available children at year 6.5, by creating a new exposure variable with 
categories representing different combinations of H. pylori and Cag A exposure status: ‘Negative’ 
(negative for both H. pylori and CagA strain), 'H. pylori positive and CagA Negative ' (positive for 
H. pylori but negative for Cag A strain) and 'H. pylori positive and CagA positive' (positive for both 
H. pylori and CagA strain).  At age 6.5 year follow up visit, the prevalence of self-reported allergy 
symptoms was low, ranging from 0.5% for eczema and hay fever to 2.2% for wheeze, we 
therefore create a new outcome variable 'Any allergic condition at age 6.5'  (i.e. positive 
response either to wheeze, or eczema, or hay fever in the past 12 months, at years 6.5 follow-
up). 
 
For longitudinal analysis of incident atopy between ages 3 and 6.5, those children without atopy 
(defined as ‘negative to any skin sensitization test (SPT), i.e. skin prick test to either 
Dermatophagoides pteronyssinus or cockroach allergen <3mm diameter) at age 3 were selected 
for analysis and incident atopy defined as a raised total serum IgE level at the year 6.5 follow up. 
Furthermore, children with self-reported allergic symptoms such as wheeze; eczema and hay 
fever at ages 3 (positive response to wheeze, eczema, and hay fever in the past 12 months, at 
years 3, and ever at year 3) were excluded for analysis of incident atopy at the year 6.5 follow 
up. 
Covariates were kept in the model if they changed the coefficient of exposure (H. pylori 
infection) by > 10% or if they were independently associated with the outcome at p < 0.10. 
Probability values < 0.05 were considered statistically significant for main effects 
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Sensitivity analysis was done to compare the distribution of demographic and life style 
variables between study subject who have complete outcome data (i.e. “complete-case”) and the 
"all respondents" populations.  
 
Ethical Approval  
The study was approved by the Institutional Review Board (IRB) of Addis Ababa University, 
College of Health Sciences, Ethiopia, and the University Of Nottingham Medical School Ethics 
Committee. Written, informed consent was obtained from the mothers after they have been 
clearly informed about the study, and in keeping with the requirements of the College of Health 
Sciences IRB all women and their children were reimbursed for health care costs. Children were 
also requested to give assent and were informed of their right to refuse to participate in the 
study and to withdraw at any time during the study without jeopardizing their right of access to 
other health services. Invasive procedures such as collection of blood samples were fully 
explained to parents and children, and were carried out using sterile disposable materials 
 
Results  
Description of cohort participants followed-up at age 6.5 years  
A detailed description of the cohort at years 1, 3, and 5 is reported elsewhere (17, 37, 43). At 6.5 
years, a total of 856 singleton children were successfully followed-up (85.1% of the original 
cohort at birth, and 99.3% of those available at year 5 follow-up), of whom 713 had total serum 
IgE measurement and 848 had H. pylori data at the 6.5 year follow up visit (Fig 1).  
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Demographic and lifestyle characteristics of study participants at 6.5-year follow-up visit 
Of children enrolled at the 6.5 year follow up visit, 51.2% (434/848) were male and the 
majority, 88.2% (748/848) were from a rural area. Maternal demographic characteristics 
showed that 47.4% (402/848) of the mothers belonged to the Meskan ethnic group, 78.4% (665 
/848) were Muslim, 71.6% (607/848) were illiterate and 83.8% were housewives (709/848). 
Most mothers (61.3%, 520/848) reported using piped water as their primary drinking source. 
Selected early life characteristics at 2 months and 1 year of age showed that 57.5% had been 
vaccinated at 2 months and only 11.7 (99/848) had received vitamin A supplementation at 1 
year (online supplementary: Table S1).   
Comparing the distribution of demographic and life style variables between all study subjects 
and those who have complete outcome data (i.e. "all respondents" and “complete-case”), found 
similar distribution patterns in relation to demographic and life style characteristics (online 
supplementary: Table S2).  
 
Prevalence of atopy and allergic conditions among children followed up at age 6.5   
The prevalence of atopy among children enrolled at the 6.5-year follow up visit was 18.1% 
(129/713), with a higher proportion among rural (20.0%) than urban (6.1%) residents, p<0.05 
(Table 2). Using an ISAAC core allergy and environmental questionnaire, wheezing was 
reported in 2.2% (18/806) of children whilst eczema and hay fever was reported in less than 
1% of the children (Table 1).  When any combination allergic condition considered, the 
prevalence reached 3.0% (24/806), with a similar proportion among urban and rural children, 
(3.1% vs. 3.0% in urban and rural, respectively, p= 0.93, Table 1).  
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Potential confounders of atopy   
The main outcome variable showed no statistically significant association with most 
demographic and lifestyle variables, including child's sex, history of vaccination, use of 
antibiotics, and intestinal parasite infection at age 6.5. Neither were family history of allergic 
conditions (maternal and paternal), common environmental factors such as household roof 
type, indoor smoking, insecticide use, and child’s sleeping place significantly associated with 
atopy. However, atopy was significantly associated with place of residence, indoor cooking, 
presence of large animal(s) inside the house, and higher numbers of older siblings (Table S3).  
 
Association between H. pylori infection and atopy or allergic conditions at age 6.5   
The prevalence of atopy was lower in children currently infected 
with H. pylori (15.2%) than in those not infected (18.6%), but this 
did not achieve statistical significance (p = 0.46). In multivariate 
analysis adjusted for a priori confounders, H. pylori infection at age 6.5 
was inversely, though not significantly, related to prevalence of 
atopy and 'any allergic condition' at age 6.5 years (adjusted OR, 
95% CI, 0.87; 0.45 to 1.70, p=0.69). When the analysis was restricted to 
those children who had H. pylori infection at age 3, 5 and 6.5 
years, or those who were ever infected up to age 6.5, a more 
pronounced reduction in odds of atopy and 'any allergic condition' 
was demonstrated. This reduction reached statistical significance 
(adjusted OR, 95% CI, 0.54; 0.32 to 0.92, p=0.02, and 0.31; 0.10 to 0.94, p=0.04, 
respectively Tables 2&3).  
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Association between CagA+ H. pylori infection with atopy and allergic condition at age 6.5  
Separate logistic regression models related atopy (outcome) to the individual estimates of CagA 
H. pylori infection status at age 6.5 years (exposure). These showed a non-significant reduction 
in the odds of atopy among H. pylori+ CagA- children (Adjusted OR=0.63, 95%CI, 0.21 to 1.87, 
p=0.63) compared to non-infected children. Children infected with CagA+ strains of H. pylori 
showed a more pronounced reduction in odds of atopy and reached a borderline significant 
association (Adjusted OR=0.35, 95%CI, 0.12 to 1.01, p=0.051)  (Table 4).   
 
 A broadly similar pattern, but non-significant inverse association was also observed between 
exposure to CagA+ H. pylori and any combination of self-reported allergic symptoms (‘any 
allergic condition') at age 6.5 (Adjusted OR=0.73, 95%CI, 0.10 to 5.56, p=0.76) 
(Table 5). 
 
Effects of H. pylori infection on incidence of atopy between ages 3 and 6.5: Longitudinal 
Analysis  
Table 6 presents the models for the longitudinal analysis between H. pylori infection and atopy 
Data are presented for the population without atopy (defined as ‘negative to any skin 
sensitisation test (SPT)) at age 3 to examine the effect of H. pylori infection at age 3 on the new 
onset of atopy (defined as raised total serum IgE level) at age 6.5. H. pylori infection at age 3 was 
inversely associated with incident atopy, after control for a priori and identified confounders 
(adjusted OR, 95% CI, 0.49; 0.27 to 0.89, p=0.02) (Table 6). Adjustment for other potential 
confounders did not materially change the odds ratio. 
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Discussion 
This study provides further evidence from a low-income, population-based birth cohort that 
current H. pylori infection at age 6.5 is inversely, though not significantly, related to prevalence 
of atopy (defined as a raised total IgE level). Any previous exposure to H. pylori infection up to 
age 6.5 was significantly associated with a 46% decreased odds of atopy.  We also explored the 
effects of CagA+ strains of H. pylori infection for the first time in this cohort at the age 6.5-year 
follow-up visit. Infection with a CagA+ H. pylori strain was associated with a 65% decreased risk 
of atopy, and reached borderline statistical significance. In longitudinal analyses, infection with 
H. pylori at age 3 was associated with a 51% decreased risk of incident atopy at age 6.5 years.  
We do not think that our findings result from selection bias for several reasons. First, the study 
cohort maintained high follow-up proportions throughout the entire study period: 85.1% of the 
original cohort at birth, and 99.3% of those available at year 5 provided data at subsequent 
follow-up. Secondly, children who had IgE measurement results did not differ with regard to 
environmental, demographic and life style variables from those who had no IgE measurements. 
We also used a highly sensitive and specific H. pylori stool antigen test (49). In addition, the key 
outcome (atopy) was defined using age-specific total IgE cutoffs, though the sensitivity and 
specificity of serum total IgE determination still remains controversial (50, 51). With normal 
values differing in their range, an upper limit of 144 IU/ml for total IgE levels in children is 
generally accepted to distinguish atopics from non-atopics (51).   
The role of total IgE as a biomarker for atopy and allergic disease has been suggested in several 
studies (39, 51-53).  Two cross-sectional studies by Burrows et al (39) and Sunyer et al (52), 
reported an independent effect of total IgE on asthma using the data from Tucson and the 
European Community Respiratory Health Survey (ECRHS) study, respectively. Others 
demonstrated a strong positive relationship between markers of the atopic syndrome and 
serum total IgE levels in children (53), and suggested total IgE as a tool to discriminate those 
with and without atopy  (51). 
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Despite these observations, however, elevated IgE levels are occasionally observed in disorders 
like parasitic infection (48), myeloma (54), and chronic inflammatory bowel diseases (55). Even 
though these conditions remain a possibility, in this cohort all study participants were 
apparently healthy children, and the magnitude of intestinal parasitosis was reported very low 
at age 3 (17). This suggests the role of intestinal parasites in modulating the immune system 
and increasing serum IgE levels is likely to be low in this study cohort.  
  
In this study, the exposure variable representing current H. pylori infection (being positive for 
stool antigen test) at age 6.5 was inversely, though not significantly, related to prevalence of 
atopy (defined as raised total IgE level). Any previous exposure up to age 6.5 (suggestive of 
early age exposure), was significantly associated with a 46% decreased risk of atopy (defined as 
raised total IgE level). Other studies have also shown no cross-sectional associations between H. 
pylori infection and raised total IgE among older children (age 7.1-15.0 years) in Finland (56), 
and in young adults in Germany and Spain (57); the latter study reported a similar magnitude of 
effect estimate as our study (OR =0.88, vs. 0.87 in the current study) (57). Failure to detect a 
significant protective effect of infections on the risk of atopy and allergic disease at age 6.5 
might be related to the age of the population being studied and/or the time of infection. Early life 
infection is considered to have a stronger protective effect due to the fact that programming of 
Th-cell memory against allergens commonly occurs during early childhood (58); the critical 
time period during which immunomodulation with long-lasting effects is considered most 
successful, probably even within the first 2 years of life (59). Thus, infections occurring later in 
childhood, may have shifted risk estimates towards no effect among the children studied, i.e., 
could have masked potentially protective effects. A study in Japan reported strong inverse 
associations between H. pylori infection and serum IgE level in younger than older adults (60). 
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Similar patterns of significant inverse associations between any previous H. pylori infection up 
to age 6.5, but not at age 6.5, with an outcome variable 'any allergic condition' (defined as a 
positive response to one or more of asthma, hay fever and eczema) also fit with previous 
observations from a large population based study in the United States, by Chen and Blaser (15), 
who used data from the 1999-2000 National Health and Nutrition Examination Survey 
(NHANES), and stratified their analysis according to participants age (3–19 years). This 
revealed a strong inverse association between H. pylori infection and onset of asthma among 
children age 2-4 years old (OR: 0.32), but this inverse association became weaker and non-
significant when the analysis was done among children age greater than 5 years (OR:0. 74). 
 
The findings of this study must, however, be interpreted with caution. Although the atopy 
outcome was measured objectively using serum IgE, measures of wheeze, eczema, hayfever and 
asthma were based on maternal questionnaire reporting, and hence are susceptible to 
misclassification and recall bias.  The questionnaire was based on the widely used and validated 
ISAAC symptoms questionnaire (44) that has been successfully used in previous studies in 
adults in Butajira (61), in under-five children  (62, 63) and in older age groups in Jimma, 
Ethiopia (8, 64), increasing the validity of our findings. 
 
This study also provides a borderline significant inverse 
association between colonization with H. pylori CagA+ strains and atopy (defined as raised 
total IgE) at age 6.5 (Adjusted OR=0.35, 95%CI, 0.12 to 1.01, p=0.051).  Most of the 
available observational studies did not investigate the role of CagA 
strains on allergic disorders in general, and on atopy (defined as raised 
total IgE) in particular. Only one study from the US National Health and Nutrition Examination 
Survey (23) reported an inverse association between colonization with H. pylori CagA+ strains  
and skin sensitization to pollen and moulds (as measured by SPT). 
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Although it may be difficult to compare the current finding due to the difference in outcome 
measurements (Total IgE vs. SPT to specific allergens), previous studies indicated a good 
correlation between an elevated total IgE and SPT in predicting atopy in children (65, 66). 
Comparing SPT to total serum IgE levels, Fajraoui et al. found that the two tests agree in 80% of 
cases (67). Matricardi et al. followed total and allergen- specific IgE levels in children from birth to 
13 years of age (68). This study revealed that the evolution of total IgE was extremely heterogeneous 
but was parallel with that of allergen-specific IgE from the age of 5 onwards.  
 
The hypothesis that more virulent CagA+ strains of H. pylori, may have a stronger protective 
effects against asthma and allergic diseases has been reported in a few epidemiological and 
animal studies (23, 24, 26). Although we found a borderline significant association in our study, 
the magnitude and direction of observed effect estimate was in the expected pattern, and our 
analyses were limited by insufficient statistical power as a result of the low prevalence of H. 
pylori infection at age 6.5 years. The low prevalence of H. pylori infection at the age 6.5 follow-up 
visit in this cohort may be linked to spontaneous elimination of the bacterium (69), or better 
attention to health issues in older children, or use of antibiotics for other common diseases (70). 
Further study is warranted to understand the exact reason of declining H. pylori prevalence in 
older children in Ethiopia.  
 
In conclusion, our study among young children from a low-income birth cohort provides further 
evidence that any exposure of H. pylori up to age 6.5, suggestive of early colonization, is 
inversely associated with atopy and any allergic condition. A modest inverse 
association with atopy was observed among children infected with the more virulent CagA+ 
strains of H. pylori. 
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Table 1.  Prevalence of self-reported allergic symptoms and atopy at age 6.5 years according to place of residence, Butajira Birth Cohort Study, 
Ethiopia.  
  
Place of residence  
Variables Overall  
N(%) 
Urban  
n(%) 
Rural  
n(%)  
Crude OR¥¥¥ 
(95 % CI) 
P-value  
Wheeze (N= 806) 18(2.2)   2(2.1) 16(2.3) 0.92(0.21 to 4.08) 0.92 
Eczema (N= 806) 4(0.5) 1(1.0) 3(0.4) 2.45(0.26 to 24.1) 0.43 
Hay-fever (N= 806) 4(0.5) 0(0.0) 4(0.6) NA NA 
Any allergic condition¥ (N=806)  24(3.0) 3(3.1) 21(3.0) 1.06(0.31 to 3.62) 0.93 
Atopy ¥¥   (N=713) 129(18.1) 6(6.1) 123(20.0) 0.26(0.11 to 0.60) <0.01 
¥Any allergic condition' was defined as a positive response either to wheeze, or eczema, or hay fever in the past 12 months, at years 6.5 follow-up  
¥¥ Atopy was defined as total serum IgE level > 144IU/ml (according to the manufacturer’s recommended threshold by age) 
¥¥¥ Crude odds ratio  (OR) was calculated using binary logistic regression  
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Table 2.  Associations between Atopy at age 6.5 years and H. pylori exposures from age 3-6.5 years, Butajira birth cohort study, Ethiopia. Cross 
sectional analysis (N=713). 
 Atopy at age 6.5 years¥  
   
Variables  
 
 
Overall  
N(%) 
 
 
 
Yes 
n(%) 
 
 
 
No 
n(%)  
 
 
 
Crude OR 
(95 % CI) 
 
 
 
 
P-value  
 
 
Adjusted OR¥¥¥¥ 
(95 % CI) 
 
 
 
 
P-value 
 Exposure to H. pylori at age 6.5        
No 634(88.9) 118(18.6) 516(81.4) 1  1  
Yes   79 (11.1) 12(15.2) 67(84.8) 0.78(0.41-1.49) 0.46 0.87(0.45 to 1.70) 0.69 
Exposure to H. pylori up to age 
6.5¥¥  (N=560) 
       
 Never infected  165(29.5) 32(19.4) 133(80.6) 1  1  
 Infected at any age up to age 6.5 393(70.5) 43(10.9) 352(89.1) 0.51(0.31-0.84) <0.01 0.54(0.32 to 0.92) 0.02 
Persistent exposure of H. 
pylori¥¥¥ 
       
No 467(95.3) 72(15.4) 395(84.6) 1  1  
Yes  23(4.7) 3(13.0) 20(87.0) 0.82(0.24-2.84) 0.76 0.93(0.26 to 3.39) 0.92 
¥ Atopy was defined as total serum IgE level > 144 IU/ml (according to the manufacturer’s recommended threshold by age) 
¥¥  Exposure of H pylori infection at any age from 3-6.5 years   
¥¥¥  H. pylori positive at both time points ( 3.5 & 6.5 years of age) 
¥¥¥¥ Adjusted for area of residence, history of maternal allergy, number of siblings and maternal education using multiple logistic regression analysis.    
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Table 3.  Associations between allergic conditions at age 6.5 years and H. pylori exposure from age 3-6 years, Butajira birth cohort study, 
Ethiopia. Cross sectional analysis   
 Any allergic conditions at age 6.5 years¥  
   
Variables  
 
 
Overall  
N (%) 
 
 
 
Yes 
N (%) 
 
 
 
No 
N (%)  
 
 
 
Crude OR 
(95 % CI) 
 
 
 
P-value  
 
 
Adjusted OR¥¥¥¥ 
(95 % CI) 
 
 
 
 
P-value 
 Exposure to H. pylori at age 6.5 
(N=797) 
       
No 716(89.8) 21(2.9) 695(97.1) 1  1  
Yes   81(10.2) 1 (1.2) 80(98.8) 0.41(0.06 to 3.12) 0.39              NA   NA 
Exposure to H. pylori up to age 
6.5¥¥ (N=559)* 
       
 Never infected  194(34.7) 9(4.6) 185(95.4) 1  1  
 Infected at any age up to age 6.5 365(65.3) 5(1.4) 360(98.6) 0.29(0.09 to 0.86) 0.03 0.31 (0.10 to 
0.94) 
0.04 
Persistent exposure to H. pylori¥¥¥  
(N=559) 
       
No 537(96.1) 12(2.2) 525(97.8) 1  NA  
Yes 22(3.9) 1(4.5) 21(95.5) 1.98(0.25 to 15.98)    
¥'Any allergic condition' was defined as a positive response to one or more of asthma, hay fever and eczema in the past 12 months, at years 6.5 follow-up 
¥¥ Exposure to H. pylori infection at any age from 3-6.5 years    
 ¥¥¥ H. pylori positive at both time points (3.5 and 6.5 years of age) 
¥¥¥¥ 
Adjusted for area of residence, maternal education and household size using multiple logistic regression analysis.   
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Table 4.  Associations between atopy at age 6.5 years and CagA H. pylori exposure at 6.5 years, Butajira birth cohort study, Ethiopia. Cross sectional 
analysis   
 Atopy at age 6.5 years a 
   
Variables  
 
 
Overall  
N (%) 
 
 
 
Yes 
N (%) 
 
 
 
No 
N (%)  
 
 
 
Crude OR 
(95 % CI) 
 
 
 
P-value  
 
 
 
Adjusted ORe 
(95 % CI) 
 
 
 
P-value 
H. pylori CagA 
status b 
       
Negative  629(88.2) 121(19.2) 508(80.8) 1 - 1 - 
cH.pylori +/ CagA  31(4.3) 4 (12.9) 27(87.1) 0.62(0.21 to 1.81) 0.38 0.63(0.21 to 1.87)      0.63 
d CagA + 53(7.4) 4(7.5) 49(92.5) 0.34 (0.12 to 0.96) 0.04 0.35(0.12 to 1.01) 0.051 
a Atopy was defined as total serum IgE level :  > 144 IU/ml (according to the manufacturer’s recommended threshold by age) 
b Exposure of CagA strain H. pylori infection at 6.5 years, c H. pylori positive but CagA strain negative, d Positive for both H. pylori and CagA strain     
e Adjusted for place of residence, history of maternal allergy, and number of older sibling, , using  multivariate  logistic regression analysis.    
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Table 5.  Associations between allergic conditions at age 6.5 years and CagA H. pylori exposure at 6.5 years, Butajira birth cohort study, 
Ethiopia. Cross sectional analysis ( N=799) 
 
 Allergic conditions at age 6.5 years¥  
   
Variables  
 
 
Overall  
N (%) 
 
 
 
Yes 
N (%) 
 
 
 
No 
N (%)  
 
 
 
Crude OR 
(95 % CI) 
 
 
 
P-value  
 
 
Adjusted OR¥¥¥ 
(95 % CI) 
 
 
 
P-value 
H. pylori CagA status ¥¥        
Negative  716(88) 21(2.9) 695(97.1) 1 - 1 - 
H. pylori + /CagA - 34(4.1) 2 (5.9) 32(94.1) 2.07(0.46 to 9.21) 0.34 2.01 (0.45 to 9.07)  0.36 
CagA + 49(6.1) 1 (2.0) 48(98.0) 0.69 (0.09 to 5.23) 0.72 0.73(0.10 to 5.56)  0.76 
¥'Any allergic condition' was defined as a positive response to one or more of asthma, hay fever and eczema in the past 12 months, at yeas 6.5 follow-up 
¥¥ Exposure to CagA strain H. pylori infection at 6.5 years   
 ¥¥¥ 
Adjusted for sex, place of residence, number of older siblings and, history of maternal and paternal allergy, using multivariate  logistic regression analysis.   
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Table 6.  Models for longitudinal association between atopy at age 6.5 and exposure to H. pylori infection at age 3 years, Butajira birth cohort study, 
Ethiopia  (N=444) 
 
 Atopy incident at age 6.5 years¥  
   
Variables  
 
 
Overall  
N (%) 
 
 
 
Yes 
N (%) 
 
 
 
No 
N (%)  
 
 
 
Crude OR 
(95 % CI) 
 
 
 
P-value  
 
 
 
Adjusted OR¥¥¥ 
(95 % CI) 
 
 
 
P-value 
 Exposure to H. pylori at age 3 
(N=444) ¥¥ 
       
No 256(57.7) 48(18.8) 208(81.2) 1  1  
Yes   188(42.3) 18(9.6) 170(90.4) 0.46(0.26 to 0.82) <0.01 0.49(0.27 to 0.89) 0.02 
¥ Atopy was defined as total serum IgE level > 144 IU/ml (according to the manufacturer’s recommended threshold by age)  
       ¥¥ Exposure to H. pylori infection at age 3 years    
       ¥¥¥ Adjusted for gender, area of residence, and number of siblings using multiple logistic regression analysis.    
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